Magenta Elevate™ Clinical Feasibility Study in Cardiogenic Shock — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Magenta Elevate™ Clinical Feasibility Study in Cardiogenic Shock — Stella

Home/Cardiogenic Shock/

View on ClinicalTrials.gov

Recruiting

Back to Cardiogenic Shock trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(5 sites)

Georgia

Israeli-Georgian Medical Research Clinic Helsicore, Tbilisi

Tbilisi Heart Center, Tbilisi

Israel

Shamir Medical Center, Be’er Ya‘aqov

Rambam Medical Center, Haifa

Tel-Aviv Sourasky Medical Center, Tel Aviv

Key details

Sponsor

Magenta Medical Ltd.

Enrollment target

~10 participants

Started

November 2025

Primary completion

May 2026

Age range

40 Years – 89 Years

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.